Hepatex-P Tablet is a pharmaceutical formulation containing L-Ornithine L-Aspartate (150 mg) and Pancreatin (100 mg), designed to support hepatic function and improve digestive enzyme activity. L-Ornithine L-Aspartate is an amino acid compound that facilitates ammonia detoxification by enhancing the urea cycle, thereby reducing blood ammonia levels commonly elevated in hepatic encephalopathy and liver dysfunction. Pancreatin is a combination of digestive enzymes including amylase, lipase, and protease, which aid in the breakdown of carbohydrates, fats, and proteins, improving nutrient absorption in patients with pancreatic insufficiency or malabsorption syndromes. Hepatex-P is indicated for use in conditions such as chronic liver diseases, hepatic encephalopathy, and exocrine pancreatic insufficiency. The synergistic action of these components helps restore metabolic balance and supports digestive health. The tablet should be administered as prescribed by a healthcare professional, considering the patient’s clinical condition and response to therapy. Caution is advised in patients with hypersensitivity to any component, and it is contraindicated in acute pancreatitis. Regular monitoring of liver function and clinical status is recommended during therapy to optimize treatment outcomes and minimize potential adverse effects.